Webinar No. 3 | July 2025
A Deep Dive into Steatotic Liver Disease Policy and Regulatory Processes
Join us for this special edition of our webinar series in EU Project LIVERAIM. Presented by The Global Think-tank on Steatotic Liver Disease and recorded live in Barcelona on 6 June 2025, this engaging roundtable brings together leading global experts, including LIVERAIM representatives Jeffrey Lazarus and Morten Karsdal, to address the under-recognised public health threat of MASLD/MASH.
With 2025 marking the UN High-level meeting on Non-Communicable Diseases, there is a clear need for effective policies and regulatory frameworks; recognising chronic liver disease, especially due to MASLD/MASH, as one of the major non-communicable diseases would be a great starting point! This webinar offers valuable insights into the current and future priorities of liver health policy and regulation.
Key Topics:
- Strategic pathways for MASLD/MASH to be included in global policy discussions
- Accelerating access to new treatments, reimbursements, and approvals
- The crucial role of payors in enabling early screening and linkage to care
- Navigating the complex regulatory landscape of drug and diagnostic approvals
Who should watch?
Clinicians involved in hepatology; health policy experts, regulatory experts, academics and researchers, industry, patient associations, patient advocates, primary healthcare professionals, gastroenterologists, hepatologists, and anyone interested in learning more about chronic liver disease from a policy perspective.
Moderators:
- Veronica Miller, PhD, Adjunct Professor IDV, Berkeley School of Public Health / Director, Forum for Collaborative Research, USA
- Jeffrey V. Lazarus, Professor, CUNY Graduate School of Public Health and Health Policy, NY, USA and the Barcelona Institute for Global Health (ISGlobal), Spain / Director, Global Think-tank on Steatotic Liver Disease
Panelists:
- Keri Hildick, Chief Strategy Officer, Perspectum, UK
- Gail Hinkson, CEO, Summit Clinical Research, LLC, USA
- Morten Karsdal, CEO, Nordic Bioscience, Denmark
- Luis Antonio Diaz Piga, Hepatologist/Researcher, MASLD Research Center, University of California San Diego, USA